Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Ibio Inc (IBIO)

1.38   0.01 (0.73%) 04-13 10:01
Open: 1.36 Pre. Close: 1.37
High: 1.38 Low: 1.35
Volume: 476,366 Market Cap: 298M
iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. The company is headquartered in New York City, New York and currently employs 7 full-time employees. The firm is focused on commercializing its technologies and product candidates and providing product development and manufacturing services to clients and collaborators. Its technologies include iBioLaunch technology and iBioModulator. The firm's technologies constitute a transformative platform for development and production of biologics in hydroponically grown green plants. The firm is focused on the commercialization of its plant-based protein expression technologies for vaccines and therapeutic proteins and on developing and commercializing select biopharmaceutical product candidates. The firm's technology is applicable in a range of product candidates, including products against fibrotic diseases, vaccines, enzyme replacements, monoclonal antibodies, and recombinant versions of marketed products that are derived from human blood plasma.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.442 - 1.453 1.453 - 1.461
Low: 1.336 - 1.349 1.349 - 1.357
Close: 1.354 - 1.373 1.373 - 1.386

Technical analysis

as of: 2021-04-12 4:54:49 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 1.95     One year: 2.17
Support: Support1: 1.36    Support2: 1.13
Resistance: Resistance1: 1.67    Resistance2: 1.86
Pivot: 1.55
Moving Average: MA(5): 1.47     MA(20): 1.60
MA(100): 1.60     MA(250): 1.92
MACD: MACD(12,26): -0.08     Signal(9): -0.07
Stochastic oscillator: %K(14,3): 11.67     %D(3): 18.61
RSI: RSI(14): 35.36
52-week: High: 7.45  Low: 0.86  Change(%): 45.7
Average Vol(K): 3-Month: 1272388  10-Days: 274427

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
IBIO has closed below the lower band by 3.2%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 49% narrower than normal. The narrow width of the bands suggests low volatility as compared to IBIO's normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Mon, 05 Apr 2021
iBio Inc. stock underperforms Monday when compared to competitors - MarketWatch

Thu, 01 Apr 2021
iBio Inc. stock outperforms competitors on strong trading day - MarketWatch

Wed, 31 Mar 2021
iBio Inc. stock outperforms market on strong trading day - MarketWatch

Tue, 30 Mar 2021
iBio Inc. stock falls Tuesday, underperforms market - MarketWatch

Fri, 26 Mar 2021
iBio Inc. stock remains steady Friday, underperforms market - MarketWatch

Thu, 25 Mar 2021
What is Wall Street's Target Price for Ibio Inc (IBIO) Stock Thursday? - InvestorsObserver

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  AMEX
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 174
Shares Float (M) 117
% Held by Insiders 8.78
% Held by Institutions 11.56
Shares Short (K) 20,000
Shares Short P. Month (K) 7,300

Stock Financials

EPS -0.975
EPS Est This Year -0.150
EPS Est Next Year -0.200
Book Value (p.s.) 0.040
Profit Margin
Operating Margin -1138.46
Return on Assets (ttm) -24.0
Return on Equity (ttm) -320.6
Qtrly Rev. Growth -81.8
Gross Profit (p.s.) 0.012
Sales Per Share 0.008
EBITDA (p.s.) -0.074
Qtrly Earnings Growth
Operating Cash Flow (M) -14
Levered Free Cash Flow (M) -8

Stock Valuations

PE Ratio -1.41
PEG Ratio
Price to Book value 34.25
Price to Sales 182.41
Price to Cash Flow -17.23

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.